Kairous Capital appeared to be the VC, which was created in 2014. The leading representative office of defined VC is situated in the Kuala Lumpur. The company was established in Asia in Malaysia.
The current fund was established by Joseph Lee, See Toh Kean Yaw. The overall number of key employees were 3.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Kairous Capital, startups are often financed by Axiata Digital Innovation Fund. The meaningful sponsors for the fund in investment in the same round are Axiata Digital Innovation Fund. In the next rounds fund is usually obtained by Vision Plus Capital, Tencent Holdings, Legend Capital.
The real fund results show that this VC is 80 percentage points more often commits exit comparing to other companies. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2018.
We can highlight the next thriving fund investment areas, such as Health Care, Internet. Among the various public portfolio startups of the fund, we may underline CareLinker, Dashubao For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
Funds with similar focus
|Altplus Inc.||Japan, Toshima|
|Barclays Private Equity||India, Maharashtra, Mumbai|
|elea Foundation for Ethics in Globalization||-|
|HeroMotoCorp Ltd||Delhi, India, New Delhi|
|Invent Ventures||California, Santa Monica, United States|
|ITT Industries||New York, United States, White Plains|
|Kaixuantong Touzi||Beijing, Beijing, China|
|Kellett Investment||Kirkland, United States, Washington|
|M. Goldschmidt Capital||Copenhagen, Denmark, Hovedstaden|
|Medpace||Cincinnati, Ohio, United States|
|Netcapital||Boston, Massachusetts, United States|
|Oclaro||California, San Jose, United States|
|Xinganxian Media Investment||China, Hangzhou, Zhejiang|
|Yield10 Bioscience||Massachusetts, United States, Woburn|
|$3M||18 Oct 2022||Midview City, Central Region, Singapore|
|01 Nov 2021||Dki Jakarta, Jakarta Raya, Indonesia|
|$1M||13 Sep 2021||Bang Rak, Krung Thep, Thailand|
|$3M||23 Apr 2021||Bang Rak, Krung Thep, Thailand|
|$1M||08 Feb 2021||Singapore, Central, Singapore|
Intrepid Group Asia
|11 Dec 2019||Jakarta, Jakarta Raya, Indonesia|
|17 Oct 2019||Shanghai, China|
|28 Dec 2018||Malaysia, Petaling Jaya|
|$3M||18 Oct 2018||Shanghai, China|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.